Quanterix Corporation QTRX Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Fulgent Genetics, Inc.FLGT

——

Revenue$36.4M+20.1%

Gross profit$15.6M+4.9%

Operating income-$41.4M-56.9%

Net income-$17.5M+14.5%

EPS (diluted)-$0.37+30.2%

Cash & equivalents$36.2M-52.7%

Total debt$35.3M-2.9%

Total equity$282.1M-10.8%

Total assets$366.7M-7.5%

Operating cash flow-$18.1M-30.4%

CapEx$87.0K-93.1%

Free cash flow-$18.2M-20.1%

Market cap$203.97M-20.1%

Enterprise value$203.12M+28.6%

P/S1.4×-0.6×

Gross margin44.2%-14.3pp

Operating margin-96.9%-1,691pp

Net margin-71.9%-2,019pp

FCF margin-57.2%-220pp

Return on equity-34.8%-122pp

Debt / equity0.1×0.0×

Current ratio3.7×-4.6×

Reported directly by Quanterix Corporation in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Quanterix Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Quanterix Corporation's available for sale securities debt securities current?: Quanterix Corporation (QTRX) reported available for sale securities debt securities current of $63.08M in Q1 2026.
How has Quanterix Corporation's available for sale securities debt securities current changed year-over-year?: Quanterix Corporation's available for sale securities debt securities current decreased by 66.9% year-over-year, from $190.37M to $63.08M.